The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug.

Navarro Coy, Nuria C; Brown, Sarah; Bosworth, Ailsa; Davies, Claire T; Emery, Paul; Everett, Colin C; Fernandez, Catherine; Gray, Janine C; Hartley, Suzanne; Hulme, Claire; +8 more... Keenan, Anne-Maree; McCabe, Christopher; Redmond, Anthony; Reynolds, Catherine; Scott, David; Sharples, Linda D; Pavitt, Sue; Buch, Maya H; (2014) The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug. BMC musculoskeletal disorders, 15 (1). 452-. ISSN 1471-2474 DOI: https://doi.org/10.1186/1471-2474-15-452

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/1471-2474-15-452

Abstract

Share

Download

Filename: The Switch study protocol_Gold VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar